[REVISION HISTORY]

Utilization of human tissue in dermatological research

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-08-23 07:46 UTC → 2026-08-23 15:42 UTC · added ~~removed~~

Research and commercial efforts are advancing in the use of discarded human biological tissue for dermatological and cosmetic applications. In South Korea, 365mc, Bundang Seoul National University Hospital, and Monitcell have partnered to develop next-generation artificial skin models. This project utilizes human fat-derived extracellular matrix (ECM) to create biological scaffolds, aiming to replace animal-derived or synthetic materials. The initiative follows a South Korean legal amendment to the Waste Management Act that allows for the recycling of human-derived fat. In the United States, Massachusetts-based startup Outer Biosciences has ~~developed a system to keep~~ emerged from stealth mode, revealing technology that keeps surgically discarded human skin tissue viable for up to 30 days. ~~The~~ Co-founded by Michael Polansky, with Lady Gaga serving on the board of directors, the company uses this living tissue to train artificial intelligence ~~models that predict~~ models. This AI predicts how specific chemical compounds affect skin functions, such as ~~pigmentation~~ collagen remodeling, pigmentation, and barrier repair. ~~This feedback loop is used~~ By feeding testing results back into the model, the company has reportedly increased the speed of identifying candidate compounds from one every 18 months to ~~identify potential cosmetic ingredient candidates.~~ approximately one every six weeks. Outer Biosciences has raised roughly $23 million and intends to license discovered biological mechanisms and ingredients to pharmaceutical and beauty companies.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.